310 related articles for article (PubMed ID: 34208031)
1. Emerging Role of microRNAs and Long Non-Coding RNAs in Sjögren's Syndrome.
De Benedittis G; Ciccacci C; Latini A; Novelli L; Novelli G; Borgiani P
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34208031
[TBL] [Abstract][Full Text] [Related]
2. Predicted Disease-Specific Immune Infiltration Patterns Decode the Potential Mechanisms of Long Non-Coding RNAs in Primary Sjogren's Syndrome.
Cheng C; Zhou J; Chen R; Shibata Y; Tanaka R; Wang J; Zhang J
Front Immunol; 2021; 12():624614. PubMed ID: 33936039
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNAs in Sjögren's Disease.
Pastva O; Klein K
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791207
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs could be potential key players in the pathophysiology of Sjögren's syndrome.
Sandhya P; Joshi K; Scaria V
Int J Rheum Dis; 2015 Nov; 18(8):898-905. PubMed ID: 26420575
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome.
Shi H; Cao N; Pu Y; Xie L; Zheng L; Yu C
Arthritis Res Ther; 2016 May; 18(1):109. PubMed ID: 27188286
[TBL] [Abstract][Full Text] [Related]
6. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.
Kapsogeorgou EK; Gourzi VC; Manoussakis MN; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2011 Sep; 37(2):129-35. PubMed ID: 21632209
[TBL] [Abstract][Full Text] [Related]
7. Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.
Jimenez SA; Piera-Velazquez S
Autoimmun Rev; 2013 Sep; 12(11):1046-51. PubMed ID: 23684698
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations in primary Sjögren's syndrome - an overview.
Imgenberg-Kreuz J; Sandling JK; Nordmark G
Clin Immunol; 2018 Nov; 196():12-20. PubMed ID: 29649576
[TBL] [Abstract][Full Text] [Related]
9. Autoantigen-targeting microRNAs in Sjögren's syndrome.
Yang Y; Peng L; Ma W; Yi F; Zhang Z; Chen H; Guo Y; Wang L; Zhao LD; Zheng W; Li J; Zhang F; Du Q
Clin Rheumatol; 2016 Apr; 35(4):911-7. PubMed ID: 26888739
[TBL] [Abstract][Full Text] [Related]
10. Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity.
Pauley KM; Stewart CM; Gauna AE; Dupre LC; Kuklani R; Chan AL; Pauley BA; Reeves WH; Chan EK; Cha S
Eur J Immunol; 2011 Jul; 41(7):2029-39. PubMed ID: 21469088
[TBL] [Abstract][Full Text] [Related]
11. Mirt2 functions in synergy with miR-377 to participate in inflammatory pathophysiology of Sjögren's syndrome.
Xin M; Liang H; Wang H; Wen D; Wang L; Zhao L; Sun M; Wang J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2473-2480. PubMed ID: 31198060
[No Abstract] [Full Text] [Related]
12. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
13. Hsa-miR-3202 attenuates Jurkat cell infiltration via MMP2 in primary Sjögren's syndrome.
Gao Q; Ye Z; Liu T; Jiang J; Jiang Z; Cao D; Zhao L
J Oral Pathol Med; 2022 Oct; 51(9):818-828. PubMed ID: 36076347
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome: novel insights from proteomics and miRNA expression analysis.
Kamounah S; Sembler-Møller ML; Nielsen CH; Pedersen AML
Front Immunol; 2023; 14():1183195. PubMed ID: 37275849
[TBL] [Abstract][Full Text] [Related]
15. Small RNA Expression Profiling Reveals hsa-miR-181d-5p Downregulation Associated With TNF-α Overexpression in Sjögren's Syndrome Patients.
Castro I; Carvajal P; Jara D; Aguilera S; Heathcote B; Barrera MJ; Aliaga-Tobar V; Maracaja-Coutinho V; Urzúa U; Quest AFG; González S; Molina C; Hermoso M; González MJ
Front Immunol; 2022; 13():870094. PubMed ID: 35432384
[TBL] [Abstract][Full Text] [Related]
16. Genetics and epigenetics in primary Sjögren's syndrome.
Imgenberg-Kreuz J; Rasmussen A; Sivils K; Nordmark G
Rheumatology (Oxford); 2021 May; 60(5):2085-2098. PubMed ID: 30770922
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.
Alevizos I; Illei GG
Autoimmun Rev; 2010 Jul; 9(9):618-21. PubMed ID: 20457282
[TBL] [Abstract][Full Text] [Related]
18. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
Nezos A; Mavragani CP
J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
[TBL] [Abstract][Full Text] [Related]
20. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
